Which drugs cannot be taken with Axitinib (Inlida) at the same time and what are the risks of taking them?

Axitinib (Axitinib) is an oral small molecule multi-target tyrosine kinase inhibitor mainly used to treat advanced renal cell carcinoma. It blocks tumor angiogenesis by inhibiting the vascular endothelial growth factor receptor (VEGFR) pathway, thereby inhibiting tumor growth. As a targeted drug, axitinib is sensitive to drug interactions in clinical practice. Therefore, attention should be paid to its combined use with other drugs during use to reduce the risk of adverse reactions and ensure efficacy.

Axitinib is primarily metabolized by the liverCYP3A4enzyme, so strong inhibitors or inducers of CYP3A4 are the main drugs to avoid. Strong inhibitors such as ketoconazole, itraconazole or clarithromycin can significantly increase the plasma concentration of axitinib and increase the risk of adverse reactions such as hypertension, proteinuria and abnormal liver function; while strong inducers of CYP3A4 such as rifampicin, phenobarbital or St. John's wort may reduce the drug concentration and affect the therapeutic effect. In addition to CYP3A4 drugs, caution is also required when using other antihypertensive drugs, anticoagulants, or cardiac drugs concurrently to avoid drug accumulation or cardiovascular toxicity.

Before coadministering medications, you should carefully consult your doctor or pharmacist to evaluate potential interactions. If simultaneous use is unavoidable, the dose of axitinib should be adjusted under the guidance of a doctor and blood pressure, blood routine and liver function monitoring should be strengthened. At the same time, patients should pay attention to potential side effects, such as sudden high blood pressure, bleeding tendencies, or gastrointestinal symptoms, and seek medical treatment in a timely manner. Proper drug management and monitoring are key to ensuring safe medication use.

While taking axitinib, patients should strictly follow the doctor's instructions and not add or stop taking other drugs at will. It is recommended to carry a medication list with you so that your doctor can refer to it when you visit. If there is a suspected drug interaction or uncomfortable symptoms, you should report it to your doctor immediately so that the plan can be adjusted in a timely manner. Through standardized medication management and safety guidance, most patients can obtain the therapeutic benefits of axitinib while controlling side effects.

Reference materials:https://www.drugs.com/